Add-on high frequency deep transcranial magnetic stimulation (dTMS) to bilateral prefrontal cortex reduces cocaine craving in patients with cocaine use disorder

Neuroscience Letters

Volumn 629, Issue , 2016, Pages 43-47

  Rapinesi, Chiara ^a   Del Casale, Antonio ^a,b   Di Pietro, Simone ^a   Ferri, Vittoria Rachele ^a   Piacentino, Daria ^a   Sani, Gabriele ^a   Raccah, Ruggero Nessim ^c   Zangen, Abraham ^d   Ferracuti, Stefano ^e   Vento, Alessandro Emiliano ^f   Angeletti, Gloria ^a   Brugnoli, Roberto ^a   D Kotzalidis, Georgios ^a   Girardi, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Department of Psychiatric Rehabilitation   (Italy)

^c ATID Ltd Advanced Technology Innovation Distribution   (Italy)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f Osservatorio sulle Dipendenze e sui Disturbi Psichici Sotto Soglia   (Italy)

Author keywords

Cocaine use disorder; Craving; Deep Transcranial Magnetic Stimulation (dTMS); Dorsolateral Prefrontal Cortex (DLPFC)

Indexed keywords

ARIPIPRAZOLE; COCAINE; OXCARBAZEPINE; TRIAZOLAM;

ADULT; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; COCAINE USE DISORDER; DEEP TRANSCRANIAL MAGNETIC STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; FOLLOW UP; HIGH FREQUENCY ELECTROTHERAPY; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION SYSTEM; TREATMENT INTERRUPTION; VISUAL ANALOG SCALE; WITHDRAWAL SYNDROME; COCAINE-RELATED DISORDERS; CRAVING; FEMALE; HEMISPHERIC DOMINANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; PROCEDURES;

ADULT; COCAINE-RELATED DISORDERS; CRAVING; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84978208729     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2016.06.049     Document Type: Article

References (39)

1. [1] Substance Abuseand Mental Health Services Administration, Overview of Findings from the 2002 National Survey on Drug Use and Health (Office of Applied Studies NHSDA Series H-21 DHHS Publication No SMA 03-3774), Rockville, MD, (2003).
2. [2] United Nations Office on Drugs and Crime, Vienna. World Drug Report 2012, New York: United Nations, (2012).
3. [3] Degenhardt, L., Whiteford, H.A., Ferrari, A.J., Baxter, A.J., Charlson, F.J., Hall, W.D., Freedman, G., Burstein, R., Johns, N., Engell, R.E., Flaxman, A., Murray, C.J., Vos, T., Global burden of disease attributable to illicit drug use and dependence: findings from the global burden of disease study 2010. Lancet 382 (2013), 1564–1574.
4. [4] Warner, L.A., Kessler, R.C., Hughes, M., Anthony, J.C., Nelson, C.B., Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 52 (1995), 219–229.
5. [5] Bridge, T.P., Fudala, P.J., Herbert, S., Leiderman, D.B., Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence. Drug Alcohol Depend. 70 (2003), S79–85.
6. [6] Dackis, C.A., Kampman, K.M., Lynch, K.G., Pettinati, H.M., O'Brien, C.P., A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30 (2005), 205–211.
7. [7] Camprodon, J.A., Martínez-Raga, J., Alonso-Alonso, M., Shih, M.C., Pascual-Leone, A., One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving. Drug Alcohol Depend. 86 (2007), 91–94.
8. [8] Politi, E., Fauci, E., Santoro, A., Smeraldi, E., Daily sessions of transcranial magnetic stimulation to the left prefrontal cortex gradually reduce cocaine craving. Am. J. Addict. 17 (2008), 345–346.
9. [9] Conti, C.L., Moscon, J.A., Fregni, F., Nitsche, M.A., Nakamura-Palacios, E.M., Cognitive related electrophysiological changes induced by non-invasive cortical electrical stimulation in crack-cocaine addiction. Int. J. Neuropsychopharmacol. 17 (2014), 1465–1475.
10. [10] Terraneo, A., Leggio, L., Saladini, M., Ermani, M., Bonci, A., Gallimberti, L., Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: a pilot study. Eur. Neuropsychopharmacol. 26 (2016), 37–44.
11. [11] Carroll, K.M., Rounsaville, B.J., Nich, C., Gordon, L.T., Wirtz, P.W., Gawin, F., One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Arch. Gen. Psychiatry 51 (1994), 989–997.
12. [12] Goldstein, R.Z., Volkow, N.D., Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 159 (2002), 1642–1652.
13. [13] Volkow, N.D., Fowler, J.S., Wang, G.J., The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 47:Suppl. 1 (2004), 3–13.
14. [14] Wilson, S.J., Sayette, M.A., Fiez, J.A., Prefrontal responses to drug cues: a neurocognitive analysis. Nat. Neurosci. 7 (2004), 211–214.
15. [15] Bechara Decision making, A., impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 8 (2005), 1458–1463.
16. [16] Naqvi, N.H., Bechara, A., The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making. Brain Struct. Funct. 214 (2010), 435–450.
17. [17] Goldstein, R.Z., Volkow, N.D., Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat. Rev. Neurosci. 12 (2011), 652–669.
18. [18] Jentsch, J.D., Taylor, J.R., Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 146 (1999), 373–390.
19. [19] Diana, M., The dopamine hypothesis of drug addiction and its potential therapeutic value. Front. Psychiatry, 2, 2011, 64.
20. [20] Dinur-Klein, L., Dannon, P., Hadar, A., Rosenberg, O., Roth, Y., Kotler, M., Zangen, A., Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective randomized controlled trial. Biol. Psychiatry 76 (2014), 742–749.
21. [21] Rapinesi, C., Kotzalidis, G.D., Serata, D., Del Casale, A., Bersani, F.S., Solfanelli, A., Scatena, P., Raccah, R.N., Brugnoli, R., Digiacomantonio, V., Carbonetti, P., Fensore, C., Tatarelli, R., Angeletti, G., Ferracuti, S., Girardi, P., Efficacy of add-on deep transcranial magnetic stimulation in comorbid alcohol dependence and dysthymic disorder: three case reports. Prim. Care Companion CNS Disord., 15, 2013, 1.
22. [22] Rapinesi, C., Curto, M., Kotzalidis, G.D., Del Casale, A., Serata, D., Ferri, V.R., Di Pietro, S., Scatena, P., Bersani, F.S., Raccah, R.N., Digiacomantonio, V., Ferracuti, S., Bersani, G., Zangen, A., Angeletti, G., Girardi, P., Antidepressant effectiveness of deep transcranial magnetic stimulation (dTMS) in patients with major depressive disorder (MDD) with or without alcohol use disorders (AUDs): a 6-month open label, follow-up study. J. Affect. Disord. 15 (2015), 57–63.
23. [23] Girardi, P., Rapinesi, C., Chiarotti, F., Kotzalidis, G.D., Piacentino, D., Serata, D., Del Casale, A., Scatena, P., Mascioli, F., Raccah, R.N., Brugnoli, R., Digiacomantonio, V., Ferri, V.R., Ferracuti, S., Zangen, A., Angeletti, G., Add-on deep transcranial magnetic stimulation (dTMS) in patients with dysthymic disorder comorbid with alcohol use disorder: a comparison with standard treatment. World J. Biol. Psychiatry 16 (2015), 66–73.
24. [24] Roth, Y., Amir, A., Levkovitz, Y., Zangen, A., Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils. J. Clin. Neurophysiol. 24 (2007), 31–38.
25. [25] Roth, Y., Pell, G.S., Chistyakov, A.V., Sinai, A., Zangen, A., Zaaroor, M., Motor cortex activation by H-coil and figure-8 coil at different depths. Combined motor threshold and electric field distribution study. Clin. Neurophysiol. 125 (2014), 336–343.
26. [26] Kravitz, A.V., Tomasi, D., LeBlanc, K.H., Baler, R., Volkow, N.D., Bonci, A., Ferré, S., Cortico-striatal circuits: novel therapeutic targets for substance use disorders. Brain Res. 1628 (2015), 186–198.
27. [27] Alba-Ferrara, L.M., Fernandez, F., de Erausquin, G.A., The use of neuromodulation in the treatment of cocaine dependence. Addict. Disord. Their Treat. 13 (2014), 1–7.
28. [28] McMillan, D.E., Gilmore-Thomas, K., Stability of opioid craving over time as measured by visual analog scales. Drug Alcohol Depend. 40 (1996), 235–239.
29. [29] Pascual-Leone, A., Houser, C.M., Reese, K., Shotland, L.I., Grafman, J., Sato, S., Valls-Solé, J., Brasil-Neto, J.P., Wassermann, E.M., Cohen, L.G., Hallett, M., Safety of rapid-rate transcranial magnetic stimulation in normal volunteers. Electroencephalogr. Clin. Neurophysiol. 89 (1993), 120–130.
30. [30] Terraneo, A., Leggio, L., Saladini, M., Ermani, M., Bonci, A., Gallimberti, L., Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: a pilot study. Eur. Neuropsychopharmacol. 26 (2016), 37–44.
31. [31] Lang, N., Hasan, A., Sueske, E., Paulus, W., Nitsche, M.A., Cortical hypoexcitability in chronic smokers? A transcranial magnetic stimulation study. Neuropsychopharmacology 33 (2008), 2517–2523.
32. [32] Moreno-López, L., Stamatakis, E.A., Fernández-Serrano, M.J., Gómez-Río, M., Rodríguez-Fernández, A., Pérez-García, M., Verdejo-García, A., Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study. PLoS One, 7, 2012, e39830.
33. [33] Bosch, O.G., Wagner, M., Jessen, F., Kühn, K.U., Joe, A., Seifritz, E., Maier, W., Biersack, H.J., Quednow, B.B., Verbal memory deficits are correlated with prefrontal hypometabolism in 18 FDG PET of recreational MDMA users. PLoS One, 8, 2013, e61234.
34. [34] Ding, X., Lee, S.W., Cocaine addiction related reproducible brain regions of abnormal default-mode network functional connectivity: a group ICA study with different model orders. Neurosci. Lett. 548 (2013), 110–114.
35. [35] Gu, H., Salmeron, B.J., Ross, T.J., Geng, X., Zhan, W., Stein, E.A., Yang, Y., Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity. Neuroimage 53 (2010), 593–601.
36. [36] Kedzior, K.K., Gellersen, H.M., Roth, Y., Zangen, A., Acute reduction in anxiety after deep transcranial magnetic stimulation (DTMS) in unipolar major depression- a systematic review and meta-analysis. Psychiatry Res. 230 (2015), 971–974.
37. [37] Rapinesi, C., Janiri, D., Kotzalidis, G.D., Serata, D., Del Casale, A., Scatena, P., Dacquino, C., Gentile, G., Manfredi, G., Danese, E., Raccah, R.N., Brugnoli, R., Callovini, G., Ferri, V.R., Ferracuti, S., Zangen, A., Simmaco, M., Angeletti, G., Girardi, P., Mitochondrial myopathy and comorbid major depressive disorder: effectiveness of dTMS on gait and mood symptoms. Gen. Hosp. Psychiatry 37:274 (2015), e7–e9.
38. [38] Berlim, M.T., Van den Eynde, F., Tovar-Perdomo, S., Chachamovich, E., Zangen, A., Turecki, G., Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression. World J. Biol. Psychiatry 15 (2014), 570–578.
39. [39] Rosenberg, O., Isserles, M., Levkovitz, Y., Kotler, M., Zangen, A., Dannon, P.N., Effectiveness of a second deep TMS in depression: a brief report. Prog. Neuropsychopharmacol. Biol. Psychiatry 35 (2011), 1041–1044.